During the past decade, CISSS de la Montérégie-Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CISSS de la Montérégie-Centre" are "Acute Copd Exacerbation" (1 trials), "Breast Cancer" (1 trials), "Hypercapnic Respiratory Failure" (1 trials) and "Neutropenia" (1 trials). Many other conditions were trialed in "CISSS de la Montérégie-Centre" in a lesser frequency.

Most popular intervention types in "CISSS de la Montérégie-Centre" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Conventional low flow oxygenation" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "High flow nasal cannula" (1 trials) and "Pegfilgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "CISSS de la Montérégie-Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CISSS de la Montérégie-Centre". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CISSS de la Montérégie-Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CISSS de la Montérégie-Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".